Hyperfine, Inc. (HYPR)

Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings

Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings

Hyperfine, Inc. (HYPR) Q2 2026 Earnings Call Transcript

Hyperfine Q2 Earnings Call Highlights

Hyperfine, Inc. Reports Second Quarter 2026 Financial Results

Hyperfine Announces the Release of Multiple Peer-Reviewed Publications, Expanding Clinical Evidence for the Swoop® System Across a Growing Number of Sites of Care

Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026

Hyperfine Announces European Launch of Next-Generation Swoop® System

Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care

Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care

Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care

Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript

Hyperfine to Join Russell 2000® and Russell 3000® Indexes

Hyperfine to Join Russell 2000® and Russell 3000® Indexes